Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.48
11.01.21
-
11.01.22
39.14%
15.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
11.01.21 70%
buy
Merck KGaA

Start price
Target price
Perf. (%)
€144.55
11.01.21
€145.00
11.01.22
42.10%
12.09.21

Could be very worthwhile Investment >20% year
Jonny5 
11.01.21 80%
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.60
11.01.21
€6.00
11.01.22
10.87%
25.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
11.01.21 50%
buy
Lumos Pharma Inc.

Start price
Target price
Perf. (%)
€18.00
11.01.21
€25.00
11.01.22
-17.22%
25.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
11.01.21 50%
buy
Evolus Inc

Start price
Target price
Perf. (%)
€3.62
11.01.21
€4.00
77.53%
25.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
11.01.21 50%
buy
4 SC AG

Start price
Target price
Perf. (%)
€2.11
10.01.21
€2.00
10.01.22
-29.15%
11.01.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Top 10 in its market
Known brand
kostojunior 
10.01.21 0%
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€2.81
10.01.21
-
10.01.22
7.84%
23.01.21

Risky Investment
DrMabuse 
10.01.21 0%
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€21.74
10.01.21
-
10.01.22
39.88%
23.01.21

Risky Investment
DrMabuse 
10.01.21 0%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.89
09.01.21
€68.00
09.01.22
8.15%
30.10.21

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
09.01.21 60%
buy
Evotec SE

Start price
Target price
Perf. (%)
€28.90
06.01.21
€40.00
-1.18%
10.03.21

Medium risks for its business
phonebroker 
06.01.21 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.93
05.01.21
-
05.01.22
10.78%
03.06.21

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Trip 
05.01.21 50%
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.05
05.01.21
-
05.01.22
-68.70%
06.01.22

Could be worthwhile Investment >10% per year
Maxi_Scalibusa 
05.01.21 0%
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.20
01.01.21
€7.00
01.01.22
-66.98%
02.01.22

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
High Investments for future growth
Geldmacher 
01.01.21 70%
sell
Tenax Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.38
30.12.20
-
30.12.21
-41.67%
31.12.21

Probably not worthwhile Investment
marge 
30.12.20 0%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€72.06
20.12.20
-
20.12.21
-7.02%
21.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
20.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.85
19.12.20
€62.00
22.06.21
7.59%
22.06.21

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
19.12.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.01
18.12.20
€45.00
-1.78%
23.12.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
18.12.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.17
18.12.20
€27.00
18.06.21
14.83%
19.01.21

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
18.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
18.12.20 80%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.56
18.12.20
-
18.12.21
8.86%
27.02.21

Innovative
Dependend from some customers or products
Higher risks for its business
ElectricPlayer 
18.12.20 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.36
18.12.20
€90.00
-3.42%
11.03.21

Could be worthwhile Investment >10% per year
Higher risks for its business
phonebroker 
18.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.67
18.12.20
€57.00
18.12.21
3.14%
09.07.21

Undervalued
Risky Investment
phonebroker 
18.12.20 50%
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€41.60
17.12.20
€48.00
17.12.21
9.86%
03.06.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
ValueFreak 
17.12.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.91
17.12.20
€29.00
-1.81%
21.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
17.12.20 50%
buy
Jaguar Health Inc.

Start price
Target price
Perf. (%)
€61.20
14.12.20
€225.00
1282.35%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%